Access to the life science market can be a headache for multinational pharma and medical device companies, let alone small-medium sized enterprises (SMEs). SMEs can face significant challenges to introduce new and innovative products into the health and social care market.
The Innovation Nexus provides a single point of access for SMEs in the life science sector to a network of specialist support within Greater Manchester.
The Innovation Nexus is a gateway to a holistic business growth support offering, focused on the specialist needs of life science SMEs, delivered through a coherent support strategy and an all-inclusive approach to helping businesses develop their growth strategies.
The aim of the Innovation Nexus is to deliver long-term health and wealth benefits to Greater Manchester through investment, innovation, education and business growth, ultimately improving the health and wellbeing of the Greater Manchester population (and beyond).
INDUSTRY PARTNERSHIP WILL BE A KEY COMPONENT OF HOW HEALTH SYSTEMS WILL IMPROVE HEALTH OUTCOMES FOR THE POPULATIONS THEY SERVE
The challenge for healthcare businesses
Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.
How can the Innovation Nexus help?
Help with navigating NHS procurement
Information about funding and investment
Help with setting up a trial of your innovation
Information on science parks and office locations in the GM AHSN footprint
Connections to organisations that can help you progress your innovation
Speak directly to a GM AHSN advisor with NHS expertise
SBRI Healthcare announces details of next competition focused on cancer diagnosis, treatment and care
SBRI Healthcare is an NHS England funded initiative led by the Academic Health Science Networks to develop technology solutions for known healthcare challenges. The next funding round focuses on finding innovative solutions with the ability to transform screening, accelerated diagnosis and management of cancer.
Cancer remains one of the public’s most feared illnesses, affecting more than one in three of us in our lifetimes. This reality means that most of us will face the anxiety of ourselves or a loved one receiving this diagnosis at some point.
We know that improving the ability to diagnose cancer – to facilitate tests that are accessible and palatable will enhance our already record high survival rates. More than half of people receiving a cancer diagnosis will now live ten years or more. But we know there is much we could do to improve patient experience and long-term quality of life, and to make our care more patient-centred.
SBRI Healthcare welcome applications from companies with solutions that can enhance the screening, diagnosis or management of cancer. Successful applicants can receive up to £100,000 of funding for phase one (feasibility) and up to £1 million for phase two (development) for solutions that match the needs of the NHS.
Sign-up at www.sbrihealthcare.com to receive the full briefing document, which be available when the application process opens at the end of July. Briefing events are planned in London and Manchester in July. Details will be available shortly.
Information and guidance
Access information and guidance on a range of topics related to working with and selling to the NHS, and find clear signposts to organisations that can help you achieve your goals.